Reena John, DO
Anesthesiology · Metairie, LANPI 1588019962
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $8,439 of the $13,885 with a category attached, or 60.8%. It is spread thinly across 29 manufacturers, the largest accounting for just 23.4%. Reporting peaked in 2022 at $5,528 and has fallen 89.5% since, to $581 in 2025. Among anesthesiology clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 241 payments — averaging $57.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$3K
- Abbott$3K
- Relievant Medsystems, Inc.$2K
- Spinal Simplicity, LLC$2K
- Painteq LLC$1K
- Revance Therapeutics, Inc.$394
- plus $2K from 23 others
What the payments were for
- Consulting fees$1,2009%
- Travel & lodging$1,86713%
- Food & beverage$8,43961%
- Education$2,37917%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 50 | $3,255 |
| Abbott | 89 | $3,132 |
| Relievant Medsystems, Inc. | 7 | $1,851 |
| Spinal Simplicity, LLC | 3 | $1,668 |
| Painteq LLC | 8 | $1,090 |
| Revance Therapeutics, Inc. | 6 | $394 |
| Nalu Medical, Inc. | 6 | $311 |
| Medtronic(2 entities) | 8 | $301 |
| Merz North America, Inc. | 3 | $263 |
| Merck | 2 | $244 |
| AbbVie | 10 | $196 |
| Forte Bio-pharma LLC | 10 | $171 |
| Interventional Pain Technologies Inc. | 1 | $134 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $112 |
| Theragen, Inc. | 1 | $100 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $98 |
| Biohaven Pharmaceuticals, Inc. | 6 | $86 |
| Stryker | 1 | $73 |
| Virtus Pharmaceuticals LLC | 3 | $69 |
| Collegium Pharmaceutical, Inc. | 4 | $62 |
| Nevro Corp. | 3 | $53 |
| Galderma Laboratories, L.p. | 3 | $52 |
| Redhill Biopharma Inc. | 2 | $34 |
| Valinor Pharma, LLC | 2 | $31 |
| Almatica Pharma LLC | 2 | $31 |
| Saluda Medical Americas, Inc. | 1 | $25 |
| Foundation Fusion Solutions, LLC | 1 | $21 |
| Amgen | 1 | $13 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$3,440
- HA MINUTEMAN G3-R$1,653
- PROCLAIM$919
- PAINTEQ$892
- VERTIFLEX SUPERION$528
- Proclaim IPG$384
- BRIDION$244
- Nalu Neurostimulation System$210
- XEOMIN$187
- Infinion 16$128
- GENERAL PAIN MANAGEMENT$127
- WAVEWRITER ALPHA$124
- Superion Indirect Decompression System$123
- CLINICAL TRIAL PRODUCT$115
- INTELLIS$111
- SPECTRA WAVEWRITER$109
- Vanta$100
- ActaStim-S$100
How this compares
$13,885 in reported general payments places this provider in the 95th percentile of 497 anesthesiology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 759 | $62,753 |
| RelistorMethylnaltrexone Bromide | 20 | $46,775 |
| ProlateOxycodone Hcl/Acetaminophen | 11 | $25,712 |
| Xtampza ErOxycodone Myristate | 25 | $20,052 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 373 | $7,635 |
| Gabapentin | 338 | $3,552 |
| Pregabalin | 94 | $3,192 |
| Oxycodone Hcl | 164 | $2,880 |
| Morphine Sulfate ErMorphine Sulfate | 82 | $2,160 |
| Methocarbamol | 160 | $1,703 |
| Tramadol Hcl | 216 | $1,630 |
| Fentanyl | 13 | $1,579 |
| Butalbital-Acetaminophen-CaffeButalb/Acetaminophen/Caffeine | 23 | $1,421 |
| Tizanidine Hcl | 187 | $1,278 |
| Cyclobenzaprine Hcl | 163 | $1,218 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $98 | $46,77520 claims |
| Forte Bio-pharma LLCProlate | $171 | $25,71211 claims |
| Collegium Pharmaceutical, Inc.Xtampza Er | $62 | $20,05225 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 497 anesthesiology providers in Louisiana.
Other anesthesiology in Metairie
- Charles DavenportMetairie$2K
- Keith MayfieldShreveport$32K
- John GuilliotNew Orleans$32K
- Brian CrenshawBenton$26K
- Caroline CarrollShreveport$26K
- Aya MouhaffelShreveport$20K
- Richard FairShreveport$17K
- Sebastian PartesottiMarrero$16K
- Wendy BernsteinShreveport$16K
- Luke MoselShreveport$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.